Lördag 17 Oktober | 06:35:44 Europe / Stockholm
Est. tid*
2027-02-16 08:30 Bokslutskommuniké 2026
2026-11-03 08:00 Kvartalsrapport 2026-Q3
2026-08-31 - Kvartalsrapport 2026-Q2
2026-05-29 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2026-05-28 - Årsstämma
2026-04-28 - Kvartalsrapport 2026-Q1
2026-03-12 - Extra Bolagsstämma 2026
2026-02-16 - Bokslutskommuniké 2025
2025-11-03 - Kvartalsrapport 2025-Q3
2025-08-29 - Kvartalsrapport 2025-Q2
2025-05-30 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2025-05-28 - Årsstämma
2025-04-25 - Kvartalsrapport 2025-Q1
2025-02-14 - Bokslutskommuniké 2024
2024-11-01 - Kvartalsrapport 2024-Q3
2024-08-30 - Kvartalsrapport 2024-Q2
2024-05-31 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2024-05-30 - Årsstämma
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-09 - Bokslutskommuniké 2023
2023-12-21 - Extra Bolagsstämma 2024
2023-11-17 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-12 - Kvartalsrapport 2023-Q1
2023-04-06 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2023-04-05 - Årsstämma
2023-02-03 - Bokslutskommuniké 2022
2022-11-07 - Kvartalsrapport 2022-Q3
2022-10-05 - Extra Bolagsstämma 2022
2022-08-26 - Kvartalsrapport 2022-Q2
2022-06-15 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2022-06-14 - Årsstämma
2022-04-29 - Kvartalsrapport 2022-Q1
2022-02-18 - Bokslutskommuniké 2021
2021-11-29 - Kvartalsrapport 2021-Q3
2021-09-23 - Extra Bolagsstämma 2021
2021-08-30 - Kvartalsrapport 2021-Q2
2021-06-28 - Årsstämma
2021-06-15 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2021-04-29 - Kvartalsrapport 2021-Q1
2021-02-19 - Bokslutskommuniké 2020
2020-11-09 - Kvartalsrapport 2020-Q3
2020-08-17 - Kvartalsrapport 2020-Q2
2020-06-26 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2020-06-25 - Årsstämma
2020-05-11 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-05-10 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2019-05-06 - Kvartalsrapport 2019-Q1
2019-04-10 - Årsstämma
2019-02-28 - Bokslutskommuniké 2018
2018-12-18 - Extra Bolagsstämma 2018
2018-10-24 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-05-24 - Kvartalsrapport 2018-Q1
2018-04-12 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2018-04-11 - Årsstämma
2018-03-22 - Bokslutskommuniké 2017
2017-08-29 - Kvartalsrapport 2017-Q2
2017-05-09 - Kvartalsrapport 2017-Q1
2017-04-26 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2017-04-25 - Årsstämma
2017-02-24 - Bokslutskommuniké 2016
2016-11-16 - Kvartalsrapport 2016-Q3
2016-10-19 - Extra Bolagsstämma 2016
2016-08-31 - Kvartalsrapport 2016-Q2
2016-04-20 - Kvartalsrapport 2016-Q1
2016-02-25 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2016-02-24 - Årsstämma
2016-02-04 - Bokslutskommuniké 2015
2015-11-13 - Kvartalsrapport 2015-Q3
2015-09-04 - Kvartalsrapport 2015-Q2
2015-07-22 - Extra Bolagsstämma 2015
2015-05-07 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2015-05-06 - Årsstämma
2015-04-17 - Kvartalsrapport 2015-Q1
2015-02-20 - Bokslutskommuniké 2014
2014-12-17 - Extra Bolagsstämma 2014
2014-11-28 - Kvartalsrapport 2014-Q3
2014-11-14 - Kvartalsrapport 2014-Q3
2014-08-29 - Kvartalsrapport 2014-Q2
2014-06-12 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2014-06-11 - Årsstämma
2014-05-16 - Kvartalsrapport 2014-Q1
2014-02-21 - Bokslutskommuniké 2013
2013-11-15 - Kvartalsrapport 2013-Q3
2013-08-28 - Kvartalsrapport 2013-Q2
2013-06-17 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2013-06-14 - Årsstämma
2013-05-17 - Kvartalsrapport 2013-Q1
2013-02-22 - Bokslutskommuniké 2012
2012-11-30 - Kvartalsrapport 2012-Q3
2012-07-31 - Kvartalsrapport 2012-Q2
2012-06-20 - X-dag ordinarie utdelning IZAFE B 0.00 SEK
2012-06-19 - Årsstämma
2012-04-20 - Kvartalsrapport 2012-Q1
2012-02-21 - Bokslutskommuniké 2011
2011-11-04 - Kvartalsrapport 2011-Q3
2011-08-12 - Kvartalsrapport 2011-Q2
2011-05-06 - Kvartalsrapport 2011-Q1
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
iZafe Group är ett Life Science-bolag inriktat på utveckling och marknadsföring av digitala medicinska lösningar för läkemedelshantering i hemmet. Bolaget erbjuder bland annat en läkemedelsrobot, SaaS-lösningar och en uppkopplad dosettask. Produkterna ämnar minska risken för felmedicinering. Kunderna utgörs av privatpersoner, läkemedelsbolag samt offentliga och privata vårdgivare globalt. iZafe Group har sitt huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

September Monthly Update – New Municipal Agreements and Launch in Iceland

2026-10-08 08:30:00

September brought new municipal agreements in Sweden and the commercial launch of Dosell in Iceland. At the same time, deliveries from the ongoing production batch continued, alongside further work on customer implementations and partner support across our markets.

In our August update, we described how our focus is increasingly shifting towards converting available units and existing agreements into active use. That direction remains unchanged. During September, we both broadened our commercial base and continued building the conditions for further installations during the autumn.

From production to active Dosell units
Production of the batch of approximately 1,300 Dosell units described in our August update has continued. By the end of September, approximately 400 units had been delivered from the factory. These units are now available for planned customer installations, with the focus on coordinating delivery, training, installation and go-live activities during the autumn.

The next step is to align deliveries with customer training, installation and start-up. It is when Dosell is put into active use and begins generating recurring revenue that the financial impact builds. An efficient process from inventory to customer is therefore important both for growth and for how we manage our working capital.

Sweden – new agreements through Adda
During September, Dosell signed agreements with the municipalities of Mora, Orsa and Älvdalen following a joint procurement under Adda’s national framework agreement. Dosell was selected as the sole supplier following an overall evaluation of price and quality.

The municipalities’ estimated requirement is approximately 120 units during the contract period. Volumes are not guaranteed, and implementation is expected to take place gradually during the winter and spring of 2026/2027, with the contracts commencing on 1 December.

These agreements are a concrete example of how Adda’s framework agreement is translating into new municipal business. In parallel, work continues with existing customers and previously awarded contracts. Training, clear working methods and follow-up after go-live are important factors in enabling municipalities to expand the use of Dosell to more users.

The Netherlands – customer follow-up and planned implementations
In the Netherlands, we continued during September to work on customer follow-up and planning for upcoming implementations. The local team has developed a concrete plan for customer activities and rollouts during the remainder of the year. The work also includes preparations for Dosell Pro and integrations with healthcare organisations’ existing systems.

The priority is to support existing customers in their day-to-day use of Dosell and ensure that planned implementations progress to installation. This requires close coordination between our local team, customers and technical support from Sweden.

Iceland – from preparations to commercial launch
In August, we described the preparations for our market introduction in Iceland. During September, Dosell became commercially available through SKAND and the Lyfja pharmacy chain, and the first customers received their units. Dosell is also available for demonstration at selected Lyfja pharmacies.

The partnership gives us a local sales channel where individuals and family members can receive advice and support before starting to use Dosell. The introduction is still at an early stage, and our focus is on supporting the first users and incorporating their feedback.

Following the end of the month, Lyfja also supported the launch with a feature article published by Vísir on 7 October. The article describes how the medication dispenser can simplify day-to-day medication management and provide support for family members. The article forms part of Lyfja’s local marketing activities and increases the visibility of the offering among potential users.

Other markets – continued partner activities
In Norway, work has continued on integrations, product support and preparations related to municipal customer processes. In Finland, the focus is on market development and planning local implementations together with our partner. The work is adapted to the conditions in each market and the steps required for customers to begin using Dosell.

Systems and ways of working for continued growth
During September, we also continued developing our own systems for administration, loading and customer follow-up. In Dosell Pro, the work has included clearer workflows for loading medication pouches, as well as improved status and alert displays.

By developing the core components of the solution ourselves, we can adapt them to customer needs and simplify the day-to-day use of Dosell. Internally, we are also developing our support for sales, delivery and follow-up. The objective is to be able to manage more customers and units without administrative resources having to grow at the same pace.

Looking ahead – execution and continued customer development
During the remainder of the autumn, we are prioritising planned implementations, development of existing customers and support for our partners. The new municipal agreements and the launch in Iceland broaden our base, while continued implementation and customer follow-up are intended to create the conditions for long-term use and recurring revenue.

We continue to work with a clear focus on making Dosell a natural part of the future of medication management.

Thank you for following our journey.